Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

For several years, reproductive immunology has been dominated by the 'Th1/Th2' hypothesis, in which the fetus avoids maternal T-cell rejection through a bias towards T-helper (Th)2 cytokine production. The discovery that normal pregnancy is a controlled state of inflammation, at an early stage at the implantation site and also later systemically, has challenged this concept, as has the finding that the predominant immune interactions in the decidua are between the placental trophoblast and maternal natural killer (NK) cells instead of T cells. Here, we extend this concept to the interaction between the trophoblast and NK cells in the maternal circulation. We suggest novel ways in which the trophoblast might stimulate the maternal systemic inflammatory response, and how dysfunctional NK-cell activation could result in the maternal syndrome of pre-eclampsia.

More information Original publication

DOI

10.1016/j.it.2006.06.009

Type

Journal article

Publication Date

2006-09-01T00:00:00+00:00

Volume

27

Pages

399 - 404

Total pages

5

Keywords

Female, Humans, Inflammation, Interferon-gamma, Killer Cells, Natural, Major Histocompatibility Complex, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Th1 Cells, Th2 Cells, Trophoblasts